Champions Oncology Inc operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Champions Oncology Inc with three other
pharmaceutical manufacturers in North America:
sales of $31.90 million
of which 81%
was Packaged sales),
of which 100%
was commercial-stage diagnostics), and
C21 Investments Inc
based in CANADA
(49.93 million Canadian Dollars [US$37.54 million]
Champions Oncology Inc reported sales of $32.12 million
April of 2020.
increase of 18.7%
versus 2019, when the company's sales were $27.07 million.
Sales at Champions Oncology Inc have increased during each of the previous five years
(and since 2015, sales have increased a total of 262%).